Organogenesis Holdings (ORGO) FCF Margin (2017 - 2026)

Organogenesis Holdings' FCF Margin history runs 10 years deep, the most recent figure standing at 48.3% for Q1 2026.

• On a quarterly basis, FCF Margin rose 7548.0% year-over-year to 48.3% in Q1 2026; TTM through Mar 2026 was 3.32%, a 516.0% increase from a year earlier, with the FY2025 full-year figure at 4.34%, down 520.0% from the prior year.
• FCF Margin advanced to 48.3% in Q1 2026 per ORGO's latest filing, from 15.41% in the prior quarter.
• Across five years, FCF Margin topped out at 48.3% in Q1 2026 and bottomed at 36.15% in Q2 2025.
• The 5-year median for FCF Margin is 0.47% (2022), against an average of 0.09%.
• Across the five-year window, FCF Margin tumbled 3724 bps in 2025 and jumped 7548 bps in 2026, its largest moves.
• Year by year, FCF Margin stood at 2.47% in 2022, then soared by 396 bps to 7.32% in 2023, then fell by 18 bps to 5.98% in 2024, then soared by 158 bps to 15.41% in 2025, then surged by 213 bps to 48.3% in 2026.
• Per Business Quant, the three latest ORGO FCF Margin figures stand at 48.3% (Q1 2026), 15.41% (Q4 2025), and 0.56% (Q3 2025).